home / stock / oncy / oncy news


ONCY News and Press, Oncolytics Biotech Inc. From 02/14/24

Stock Information

Company Name: Oncolytics Biotech Inc.
Stock Symbol: ONCY
Market: NASDAQ
Website: oncolyticsbiotech.com

Menu

ONCY ONCY Quote ONCY Short ONCY News ONCY Articles ONCY Message Board
Get ONCY Alerts

News, Short Squeeze, Breakout and More Instantly...

ONCY - Anal Cancer Treatment Market Expected to Reach $1.63 Billion by 2030 as Latest Clinical Studies Focus on New Therapies

PALM BEACH, Fla., Feb. 14, 2024 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - Recent reports project that the anal cancer market will continue its recent growth through 2030. An article on the MD Anderson website. It said: “More than 8,000 people in the U.S. are diag...

ONCY - Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort

Oncolytics Biotech® Initiates Enrollment Expansion of GOBLET Anal Cancer Cohort Canada NewsWire Successful Stage 1 data showed a near tripling of Objective Response Rate compared to checkpoint inhibitor monotherapy, including a Complete Response, and supports expansi...

ONCY - Pancreatic Cancer Treatments Poised for Major Advances in 2024

2024-02-07 08:55:30 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – February 7, 2024 – USA News Group –  One of the more worrying storylines of 2023 was the rising incidence of early-onset pancreatic cancer ...

ONCY - Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

2024-01-09 10:25:55 ET Palm Beach, FL – January 9, 2024 – According to the report titled “Aging in the United States,” published by the Population Reference Bureau, “the number of Americans aged 65 and older is projected to increase more than double over 9...

ONCY - Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors

Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors Canada NewsWire SAN DIEGO and CALGARY, AB , Jan. 9, 2024 /CNW/ --  Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics company focuse...

ONCY - Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024

Oncolytics Biotech® Recaps 2023 Accomplishments, Provides Outlook for 2024 Canada NewsWire SAN DIEGO , CA and CALGARY, AB , Jan. 4, 2024 /CNW/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC), a clinical-stage immunotherapeutics comp...

ONCY - Oncolytics Biotech: Numerous Early Readouts, But Dwindling Reserves

2023-12-11 07:24:11 ET Summary Oncolytics Biotech is developing an oncolytic virus therapy for solid tumors, but data readouts remain early and cash is a serious concern. The company's sole product in development is an oncolytic virus called pelareorep, which has shown early evide...

ONCY - Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS

Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS Canada NewsWire Pelareorep induced prominent expansion of pre-existing Tumor Infiltrating Lymphocytes (TILs) in the blood and new TILs in the tumor Data highlights the association between t...

ONCY - Improving Survival Rates: Biotech Innovations in Pancreatic Cancer Treatment

2023-11-29 10:45:34 ET FN Media Group Presents USA News Group News Commentary Vancouver, BC – November 29, 2023 – USA News Group –  According to the European Cancer Information System (ECIS), new cancer cases and deaths are on the ri...

ONCY - Global Anal Cancer Market Size Expected to Reach $1.24 Billion In 2028 as Treatments Advance

2023-11-09 08:45:53 ET Palm Beach, FL – November 9, 2023 – FinancialNewsMedia.com News Commentary – According to the American Cancer Society projections, there were around 9,440 new instances (3,150 in men and 6,290 in women) and about 1,670 fatalities (930 ...

Previous 10 Next 10